Viewing Study NCT00435812


Ignite Creation Date: 2025-12-26 @ 10:19 PM
Ignite Modification Date: 2026-04-15 @ 11:03 AM
Study NCT ID: NCT00435812
Status: COMPLETED
Last Update Posted: 2019-03-20
First Post: 2007-02-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy of HEPLISAV™ Hepatitis B Virus Vaccine Compared With Engerix-B® Vaccine
Sponsor: Dynavax Technologies Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis B View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HBV vaccine View
None Hepatitis B vaccine View
None Hepatitis B View
None Hepatitis View
None HBV View
None Immunostimulatory sequence (ISS) View